BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cefoperazone

a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections.

300+ PubMed studies analyzed · 39 RCTs · Evidence Score: 49.9

Research Domains

Cefoperazone has been studied across 10 research domains including 🫘 Kidney, 🫁 Liver & Detox, 🫁 Respiratory, 😴 Sleep, 🦠 Gut & Microbiome. The primary research focus is 🫘 Kidney with 7% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cefoperazone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Ceftriaxone
10 shared targets
Cefamandole
6 shared targets
Cefmetazole
4 shared targets
Cefoxitin
4 shared targets
Nateglinide
5 shared targets
Lamotrigine
5 shared targets
Delavirdine
6 shared targets
cefotaxime
3 shared targets
cefuroxime
3 shared targets
cefadroxil
3 shared targets
Loading evidence profile...

This evidence profile for Cefoperazone is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.